Abbott Laboratories' (NYSE: ABT) business has been a bit of a roller coaster. The pandemic disrupted its medical device ...

However, patients can purchase FreeStyle Libre devices only through prescription, at least in the U.S. (That's not the case in some other countries.) In June, Abbott Laboratories announced that ...

Abbott (NYSE: ABT) today announced U.S. availability of Lingo™, the company's first continuous glucose monitoring system available without a prescription. The Lingo system includes a biosensor and a ...

Among the many corporations that pay a dividend, some do so unpredictably and irregularly. Others rarely raise their payouts ...

RHHBY's Accu-Chek Smartguide will provide several predictive features aimed at enhancing patient safety. However, the device ...

Perhaps none is more important than its continuous glucose monitoring (CGM) franchise, the FreeStyle Libre. It has been its best-performing device for years, but as Abbott reported earlier this ...

Perhaps none is more important than its continuous glucose monitoring (CGM) franchise, the FreeStyle Libre. It has been its ... Before you buy stock in Abbott Laboratories, consider this: The ...

The announcement comes just after Dexcom, another diabetes company, released its own consumer-friendly sensor. Here's what to ...

Users can buy a one-month supply online for $99 (for ... These systems are based on Abbott’s FreeStyle Libre technology, ...

You can use your FSA or HSA dollars to purchase it. Lingo has already been ... Abbott's over-the-counter CGMS are based on its popular FreeStyle Libre sensor technology, as Dexcom's prescription ...